<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04149288</url>
  </required_header>
  <id_info>
    <org_study_id>1484263</org_study_id>
    <nct_id>NCT04149288</nct_id>
  </id_info>
  <brief_title>Olive Oil Polyphenols and Cardiovascular Health Biomarkers</brief_title>
  <official_title>Olive Oil Polyphenols and Cardiovascular Health Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to investigate whether consuming two different kinds of olive
      oil will change risk factors related to cardiovascular disease, including levels of good and
      bad cholesterol, levels of inflammation, and levels of gene expression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research is to investigate whether consuming two different kinds of olive
      oil will change risk factors related to cardiovascular disease, including levels of good and
      bad cholesterol, levels of inflammation, and levels of gene expression. Healthy individuals
      aged 20-45 with a BMI over 20 kg/m2 are eligible to participate. The study involves 5 visits
      (1 initial screening and 4 study visits) and will last about 8 weeks. There is a 2-week
      run-in period before starting the study, followed by two diet intervention periods each
      lasting two weeks, separated by a two-week washout period.

      Participation in this study will involve an initial two-week run in period to become
      accustomed to the study diet. After this two week period, participants will be randomly
      selected to start either a high-polyphenol olive oil (extra virgin olive oil) or a
      low-polyphenol olive oil (refined olive oil); participants will consume the other oil during
      the second dietary intervention period lasting 2 weeks. During each phase of the study,
      participants will be asked to come to the UC Davis campus after a 10-12 hour overnight fast.
      At each visit, body measurements will be taken, a serving of olive oil and bread will be
      eaten, and three urine and blood samples will be collected over the course of 4 hours. Each
      study visit will involve three blood draws by a trained nurse or phlebotomist.

      During the 8 weeks of the study, all olive products such as olives, olive oil, and olive
      containing products will need to be avoided. The study will provide olive oil to be eaten at
      home for each intervention phase. Additionally, the investigators will ask that nuts and
      high-polyphenol foods (mostly fruits and vegetables) be avoided in the diet. Detailed food
      diaries will be filled out and brought to study visits.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on cholesterol efflux</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Cholesterol efflux will be measured by assessing changes in reverse cholesterol transport rate in separated serum at each study time point (baseline, 2 hour, 4 hour) using a commercially available assay kit at each of the 4 study visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on cholesterol ester transfer protein activity (CETP)</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Changes in CETP activity will be measured at each study time point (baseline, 2 hour, 4 hour) in plasma at each of the 4 study visits. The isolated plasma will be co-incubated with donor and acceptor molecules using a commercially available assay kit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on circulating oxidized LDL</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure for changes in circulating levels of oxidized LDL in separated plasma at each study time point (baseline, 2 hour, 4 hour) using a commercially available ELISA kit; measured in units of U/L at each of the 4 study visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on blood lipid measurements</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure for changes in the levels of HDL and LDL in separated plasma; measured in units of mg/dL. Blood will be assessed for the fasting (baseline) sample only at each of the 4 study visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on paraoxinase-1 (PON-1) activity</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure for changes in PON-1 activity in separated plasma at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Activity will be calculated based on linear rates of hydrolysis of phenyl acetate to phenol.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on peripheral blood mononuclear cells (PBMC) using ex vivo stimulation assays</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measurement of changes in PBMC derived cytokines as a marker of inflammation at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Assessment will be based on an increase or decrease in concentration in pg/ml.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing the influence of olive oil polyphenols on gene expression in mirco RNA in PBMCs</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure level of gene expression in micro RNA from PBMCs at each study time point (baseline, 2 hour, 4 ) at each of the 4 study visits. Assessment will be based on fold change between study arms.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Food record anaylsis</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Use a computer program to check for study dietary requirements. Subjects are to avoid olives and olive containing products during study protocol periods. This will be done using a subject self-recorded 3-day food record submitted to study personnel.</description>
  </other_outcome>
  <other_outcome>
    <measure>Anthropometric measurements</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure waist (cm) and hip circumference (cm) before the start of drawing blood on study day protocols.</description>
  </other_outcome>
  <other_outcome>
    <measure>Measure for changes in weight</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure weight (kg) before the start of drawing blood on study day protocols.</description>
  </other_outcome>
  <other_outcome>
    <measure>Measure for changes in blood pressure</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure blood pressure (mmHg) before the start of drawing blood on study day protocols.</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessing the influence of olive oil polyphenols on circulating cytokines</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Measure circulating cytokines in separated plasma at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Commercially available ELISA kits will be used: TNF-a, IL-6, IL-1B, MCP-1, and ET-1.</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessing the influence of olive oil polyphenols on urine metabolites</measure>
    <time_frame>Through study completion, an average of 8 weeks</time_frame>
    <description>Metabolomics will be performed on urine to assess for study compliance of consumption of the polyphenol containing olive oil versus the low-polyohenol containing olive oil at each of the 4 study visits.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Healthy</condition>
  <condition>Normal Weight</condition>
  <condition>Overweight</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>High-polyphenol olive oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume 40 mL of high-polyphenol olive oil each day at home for 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-polyphenol olive oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume 40 mL of low-polyphenol olive oil each day at home for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High-polyphenol olive oil</intervention_name>
    <description>High-polyphenol olive oil will be provided to study participants to consume at home. Participants will be asked to consume 40 mL each day for 2 weeks.</description>
    <arm_group_label>High-polyphenol olive oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low-polyphenol olive oil</intervention_name>
    <description>Low-polyphenol olive oil will be provided to study participants to consume at home. Participants will be asked to consume 40 mL each day for 2 weeks.</description>
    <arm_group_label>Low-polyphenol olive oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Generally healthy male and female subjects within the range of 20-45 years of age and
             BMI range of 18.5-29.9 kg/m2 for the healthy weight/overwight group and â‰¥ 30 kg/m2 for
             the obese group will be recruited.

        Exclusion Criteria:

          -  Adults unable to consent, individuals who are not yet adults (infants, children,
             teenagers), pregnant or lactating women, women planning to become pregnant in the next
             two months and prisoners will be specifically excluded

          -  Documented chronic diseases including diabetes, thyroid disease, kidney disease,
             metabolic syndrome, active cancer, previous cardiovascular events, history of gastric
             bypass or other GI issues related to fat absorption

          -  History of dyslipidemia or abnormal blood glucose levels (total cholesterol &gt;240
             mg/dL, elevated fasting blood glucose levels &gt;125 mg/dL)

          -  Allergy to olives, inability to tolerate gluten or multiple allergies/intolerances
             that would significantly limit food intake

          -  Smoker or living with a smoker, illicit drug use, consuming &gt;1 alcoholic drink/day,
             vaporizer and/or electronic cigarette use

          -  Extreme dietary or exercise patterns

          -  Recent weight fluctuations (&gt;10% in the last 6 months)

          -  Taking prescription lipid medications or supplements that may affect lipoprotein
             metabolism, &gt;1 g of fish oil/day, antioxidant supplements, CBD oil

          -  Taking exogenous hormones (e.g. hormonal birth control)

          -  Poor venous access

          -  Unwillingness to comply with study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francene M Steinberg, PhD, RD</last_name>
    <phone>(530) 752-0160</phone>
    <email>fmsteinberg@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jody Randolph, MS</last_name>
    <phone>(530) 752-7620</phone>
    <email>jmrandolph@ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ragle Human Nutrition Center</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

